STAT+: Drugmakers guard IP more tightly amid China competition

Parabilis Medicines has filed to go public under the symbol PBLS. Former FDA commissioner David Kessler expressed confidence in Kyle Diamantas, the new interim FDA chief. The development comes amid increased competition from China in the biotech industry.